AxonAI, Inc. uses proprietary, swarm-based artificial intelligence to autonomously discover patterns and anomalies, coordinate resources, predict behavior, and much more.

More information is available on the AXON AI website.

Axon Dx is a biomolecular company developing a scanning instrument and accompanying methodology for rapid, minimally invasive cancer and rare cell detection. The company’s products include the nCyte Dx™, a scanning instrument that detects circulating tumor cells (CTCs) in a blood sample. The instrument will be marketed to researchers, cancer centers, medical centers, and clinics for point-of-care monitoring and diagnosis.

More information is available on the AXON DX website.


AXON Optics is an optical instrument company currently commercializing a device capable of detecting breaks, flaws, and unauthorized tampering in fiber optic cable.